Skip to content

Gatekeeper for Soiling and Gas Incontinence

Gatekeeper™ Prostheses Implants for Patients With Gas Incontinence and Soiling

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05222217
Enrollment
13
Registered
2022-02-03
Start date
2014-01-31
Completion date
2015-12-31
Last updated
2022-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gas Incontinence, Soilings, Fecal

Brief summary

Faecal incontinence has a broad spectrum of symptoms. Some patients only suffer commonly considered mild symptoms: gas incontinence and soiling, but patients' quality of life is significantly impaired. Although several treatments for faecal incontinence are available, this subgroup of patients are difficult to treat, and no therapeutic alternative has been clearly defined. The aim of this study is to evaluate Gatekeeper™ treatment for this subgroup of patients with faecal incontinence, not studied before. Consecutive case series single-centre study. Patients with mainly soiling and/or gas incontinence were treated with polyacrylonitrile prostheses

Interventions

Six polyacrylonitrile prostheses (THD Gatekeeper™ Delivery System, THD SpA, Correggio, Italy) were implanted under 3D-EUS control through a 5mm perianal incision at 1, 3, 5, 7, 9 and 11 o'clock in lithotomy position, and located in the upper-middle intersphincteric space of the anal canal, using a specifically designed system.

Sponsors

Hospital Mutua de Terrassa
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients older than 18 years old * with at least 6 months of GI and/or soiling * non-responding to conservative treatment and biofeedback.

Exclusion criteria

* complete solid and liquid FI * common Bristol score \> 4 * malignant diseases * chronic diarrhoea * inflammatory bowel disease * acute anorectal disease * rectal prolapse * neurological disease, * obstructive defecation syndrome * low anterior resection syndrome, * previous pelvic radiation, * any anaesthetic contraindication * St. Mark's score \> 12 * external anal sphincter lesion \> 30º.

Design outcomes

Primary

MeasureTime frameDescription
Change in the number of gas incontinence and soiling episodes6, 12 and 24 months after surgeryEach patient completes a three-week continence diary specifically recording gas incontinence and soiling episodes at baseline and before every follow-up visit.
Changes in incontinence symptoms6, 12 and 24 months after surgeryEvaluation of incontinence symptoms with the St. Mark's Incontinence Score. Score from 0 to 24, where 0 means complete continence and 24 means severe fecal incontinence
Patient's Subjective Perception6, 12 and 24 months after surgeryChanges in patient subjective evaluation using a Visual Analogue Scale (VAS). Score from 0 to 10, where 0 means no problem and 10 means severe problem and alteration of my quality of life

Secondary

MeasureTime frameDescription
Changes in prostheses locationbaseline and one month after surgeryProstheses migration was defined as displacement of the prosthesis to the suprasphincteric space detected during the follow-up, detected with 3D-Endoanal Ultrasound.
Differences in anal pressuresbaseline and three months after surgeryMeasurement of differences in anal testing pressures using a four-channel manometer

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026